Pazopanib is sold as Votrient in India; it’s the registered trade name. It is developed and facilitated by Novartis, a global Pharma leader. They have a very good presence in India as well. They manage Pazopanib access and supply with the help of authorized stockists and distributors. Pazopanib or Votrient Price is limited by the MRP. This drug is supplied to speciality Pharmacies that are licensed to handle Cancer Care Medicines in India. Novartis may offer special approvals and cost to the patients. They have the option of rolling out patient support programs from time to time.
Votrient Price in India wouldn’t vary from one city to another. The commercial strategy is based on time-tested operational practices. Accordingly, the authorized suppliers are advised on the pricing guidelines. However, the international prices may be different from the existing Pazopanib cost in India. To some extent, it is a reality that the Indian market has better cost advantage. Patients with insurance coverage would benefit just like those with institutional reimbursements in many cases. Technically this drug is prescribed by a registered Medical Oncologist in India.
Votrient 200mg and Votrient 400mg are commercial strengths. Access to this drug is not a major hassle. But, patients can explore more options and possibilities considering the cost dynamics. We can help with fair assessment when it comes to the cost and availability of speciality medications. Talk to us to understand if the information you have from your Pharmacy is accurate or not. There may be alternative options for you.